NFKB1 and hepatocellular carcinoma: In this study, unlike our previous studies, the effects of cucurbitacins on the Akt/IκB/NF-κB inflammatory signaling pathway, COX-2, and NO inflammatory markers in hepatocellular carcinoma were evaluated compared with sorafenib.